Author:
Zheng Yuhong,Chen Yan,Hu Minhua,Lin Yingying,Chen Yansong
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin, 2012, 62: 10–29.
2. Carison RW, Allred DC, Anderson BO, et al. NCCN Clinical Practice Guidelines in Oncology-Breast Cancer V1. 2012. National Comprehensive Cancer Network, 2012, January.
3. Sturgeon CM, Duffy MJ, Stenman UH, et al. National Academy of Clinical Biochemistry Guidelines for the use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem, 2008, 54: e11–79.
4. Uehara M, Kinoshita T, Hojo T, et al. Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA15-3) in breast cancer. Int J Clin Oncol, 2008, 13: 447–451.
5. Yerushalmi R, Tyldesley S, Kennecke H, et al. Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. Ann Oncol, 2012, 23: 338–345.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献